CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.
…
continue reading
CTI Clinical Trial Podcasts
1
Building Strong Site-CRO Partnerships: Insights from ASN 2025
11:36
11:36
Play later
Play later
Lists
Like
Liked
11:36Recorded live at ASN 2025 in Houston, this episode of Moving Medicine Forward features Courtney Cordero, Director of Therapeutic Strategy at CTI, in conversation with Morgan Terry, Site Director at Eastern Nephrology Associates. Together, they explore what makes a healthy and productive partnership between clinical research sites and CROs, the crit…
…
continue reading
1
The Science of Compassion: Advancing Oncology Trials
16:48
16:48
Play later
Play later
Lists
Like
Liked
16:48In this inspiring episode of Moving Medicine Forward,Amanda King, Senior Clinical Scientist at CTI, discusses her remarkable journey from pediatric ICU nurse practitioner to leading-edge oncology researcher. Amanda shares how personal loss fueled her passion for patient-centered careand clinical research, and how her work at the NIH and CTI is shap…
…
continue reading
1
What Makes a Great CRO: Insights with Joel White
24:49
24:49
Play later
Play later
Lists
Like
Liked
24:49Joel White, Owner of Marketcap Consulting, joins another episode to discuss the evolving role of Clinical Research Organizations (CROs). He shares the characteristics of a great CRO, how technology and decentralization are shaping the industry, and the strategic balance between speed, quality, and cost in clinical trials. Whether you're a sponsor, …
…
continue reading
Chuck Scheper, Board Chair at Bexion Pharmaceuticals, shares how a stage IV non-Hodgkin lymphoma diagnosis at age 39 and a life-saving clinical trial led to his lifelong commitment to cancer research. He joins Tim Schroeder, CEO and Chairman of CTI, to discuss the founding of VaxCella, the evolution of cancer therapies, the importance of patient-ce…
…
continue reading
1
Cautious Optimism: The State of Clinical Research in 2025
32:44
32:44
Play later
Play later
Lists
Like
Liked
32:44In this episode, host Jeremy Schrand is joined by Tim Schroeder, Chairman, CEO, and Founder of CTI, and Joel White, Owner of Marketcap Consulting, for a broad discussion on the clinical research industry. Topics include recent industry developments, biotech funding challenges, leadership in clinical trials, corporate citizenship, and predictions fo…
…
continue reading
1
Funding Hope: How CancerFree KIDS Is Powering Pediatric Cancer Breakthroughs
32:41
32:41
Play later
Play later
Lists
Like
Liked
32:41In this special episode, host Jeremy Schrand sits down with Jill Brinck, Executive Director of CancerFree KIDS, and Dr. Genevieve Kendall, a CancerFree KIDS grant recipient and pediatric cancer researcher at Baylor College of Medicine. Together, they explore the power of early-stage research funding, the challenges and breakthroughs in treating chi…
…
continue reading
1
Redefining Possibility: CTI’s Role in Cell and Gene Therapy Trials
19:33
19:33
Play later
Play later
Lists
Like
Liked
19:33In this episode of Moving Medicine Forward, host Jeremy Schrand welcomes Dr. Rich Curry to discuss how CTI is helping redefine what’s possible in clinical research. From the complexities of cell and gene therapy to the human stories behind the science, Dr. Curry shares how CTI’s expertise in rare diseases and regenerative medicine is accelerating i…
…
continue reading
1
Spotlight: Savannah Doliboa, Chief Commercial Officer at CTI
11:02
11:02
Play later
Play later
Lists
Like
Liked
11:02In this episode of “Moving Medicine Forward,” SavannahDoliboa, Chief Commercial Officer at CTI, shares her career journey and what led her to CTI, a company that combines the strengths of both large and mid-sized CROs. She reflects on the rewards of working with rare disease sponsors, CTI’s diverse client base, and its reputation for flexibility, e…
…
continue reading
1
Pitt Hopkins Research Foundation: A Mother's Story of Hope
20:37
20:37
Play later
Play later
Lists
Like
Liked
20:37In this episode of “Moving Medicine Forward,” Audrey Davidow shares how her son’s diagnosis led to her co-founding the Pitt Hopkins Research Foundation. She explains the rare genetic disorder, the foundation’s focus on research and family support, and major breakthroughs such as a gene therapy trial. Audrey also reflects on advocacy, leadership cha…
…
continue reading
1
Clinical Research in the Middle East & Africa: A Conversation with Alaa Assem from CTI
18:07
18:07
Play later
Play later
Lists
Like
Liked
18:07Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials. T…
…
continue reading
1
CAR-T Explained: The Science Behind Personalized Immunotherapy
14:25
14:25
Play later
Play later
Lists
Like
Liked
14:25In this episode of “Moving Medicine Forward,” Tara Mink,expert in cell and gene therapy for more than 25 years, joins to discuss the science, promise, and challenges of CAR-T therapy. Tara explains how CAR-T works, its remarkable durability, and the side effects clinicians manage. She also discusses the future of gene therapy, barriers to access, a…
…
continue reading
1
Why Strategic Financial Planning is Critical to Advancing Clinical Trials
15:30
15:30
Play later
Play later
Lists
Like
Liked
15:30In this episode of “Moving Medicine Forward,” host Jeremy Strand sits down with Brian Lawrence, Chief Financial Officer at CTI, to explore how strategic financial planning is critical to advancing clinical trials, particularly in rare disease research. Brian shares insights on balancing profitability with purpose in one of the world’s most highly r…
…
continue reading
1
Feasibility in Focus: Building Better Transplant Trials
13:16
13:16
Play later
Play later
Lists
Like
Liked
13:16What makes a clinical trial site successful when managing complex transplant studies? In this episode of “Moving Medicine Forward,” host Jeremy Schrand is joined by Shawna Bredek, a 20+ year veteran in clinical trial operations, to explore how feasibility assessments shape the future of life-saving research. Shawna shares how her team evaluates sit…
…
continue reading
1
Inside the World's Busiest Kidney Transplant Center
39:02
39:02
Play later
Play later
Lists
Like
Liked
39:02In this episode of Moving Medicine Forward, we sit down with Dr. Helios Tedesco, a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world’s largest kidney transplant programs. Joined by CTI experts Dr. Christopher Boshkos, Senior Medical Director, and Clinical Scientist, Erika Aldag, the conversation explores…
…
continue reading
1
Spotlight: Jamie Meisenhelder, Chief Administrative Officer at CTI
14:12
14:12
Play later
Play later
Lists
Like
Liked
14:12In this episode of “Moving Medicine Forward” – The Podcast, Jamie Meisenhelder, Chief Administrative Officer (CAO) at CTI, joins us to reflect on her unique journey from law to leadership and how she oversees CTI’s legal, QA, and administrative functions. She shares how her team supports clinical trials, tackles global regulatory challenges, mainta…
…
continue reading
1
Life Changing Connections: A Conversation with Network for Hope Advocates
28:44
28:44
Play later
Play later
Lists
Like
Liked
28:44In this episode, Jeremy sits down with Sara Russo and John Mock from Network for Hope, an independent nonprofit organ procurement organization. Together, they explore the life-changing work of organ and tissue donation — from the hospital bedside to the recipient's second chance at life. Learn how the organization evolved from a merger between Life…
…
continue reading
1
Insights from CTI Global Lab Experts Monica Rodriguez & Andy Supp
14:29
14:29
Play later
Play later
Lists
Like
Liked
14:29In this episode of “Moving Medicine Forward” – The Podcast, Monica Rodriguez, Managing Director of Global Laboratory, Pharmacometrics, and Site Services at CTI, and Andy Supp, Vice President of Global Laboratory Services at CTI, join the conversation to discuss the unique structure and capabilities of CTI’s global laboratories. They share insights …
…
continue reading
1
Spotlight: Pat Dearing, Chief Human Resources Officer at CTI
19:48
19:48
Play later
Play later
Lists
Like
Liked
19:48In this episode of “Moving Medicine Forward” – The Podcast, Pat Dearing, Chief Human Resources Officer at CTI, discusses his career journey and the unique challenges of HR in healthcare. He shares insights on recruiting top talent, "people-first leadership," and CTI's DEIB council. Pat also talks about the future of remote work, HR’s role in acquis…
…
continue reading
1
Navigating Rare Disease Advocacy: The CurePDE Journey
54:25
54:25
Play later
Play later
Lists
Like
Liked
54:25In this episode of “Moving Medicine Forward” – The Podcast, Christine Eby, Director of Clinical Project Management & Therapeutic Strategy Lead at CTI, Anna Sowa, Chief Mission Officer at CurePDE, Curtis R. Coughlin II, PhD, MS, MBE, Associate Professor, Department of Pediatrics and Center for Bioethics and Humanities, and Kristy McCay, mom of a two…
…
continue reading
1
Unraveling Rett Syndrome: A Mom's Journey Through a Rare Genetic Disease
10:39
10:39
Play later
Play later
Lists
Like
Liked
10:39In this episode of "Moving Medicine Forward" – The Podcast, Jill Black, Validation IT Principal Auditor at CTI, shares the deeply personal story of her daughter, Emma, and their journey navigating this rare disease. She offers valuable insights into the challenges and impact of Rett Syndrome, while discussing her work at CTI and how being part of a…
…
continue reading
In this episode of “Moving Medicine Forward” – The Podcast, Mike Vieth, CTI Board Member and partner at E Gateway Capital, and Tim Schroeder, CTI CEO and Chairman, explore key topics in clinical trial funding. They discuss the role of venture capital in overcoming funding challenges, balancing high-risk investments, and supporting clinical research…
…
continue reading
1
Blood Cancer Trials Decoded: Navigating Multiple Myeloma and Acute Myeloid Leukemia
24:27
24:27
Play later
Play later
Lists
Like
Liked
24:27In this episode of #MovingMedicineForward – The Podcast, CTI experts Chad Jones & Eric Clayton discuss challenges in clinical research surrounding Acute Myeloid Leukemia (AML) & Multiple Myeloma (MM). They explore the complexities of designing & conducting clinical trials, the importance of site selection, & how CTI’s expertise enhances trial outco…
…
continue reading
1
ABTA: Raising Awareness, Providing Support & Funding Research
22:09
22:09
Play later
Play later
Lists
Like
Liked
22:09In this episode of “Moving Medicine Forward” – The Podcast, Lily McNally and Heidi Shenk from the American Brain Tumor Association (ABTA) share their personal connections to brain tumors and discuss the ABTA’s resources, research initiatives, and community partnerships. They also discuss ABTA’s “Meet Hope Head On” campaign to triple research fundin…
…
continue reading
1
DCM Foundation: The Journey from Diagnosis to Advocacy Group
37:49
37:49
Play later
Play later
Lists
Like
Liked
37:49In this episode of "Moving Medicine Forward" - The Podcast, Greg Ruf, Founder & Executive Director of the DCM Foundation, and Bret Marshall, Senior Director of Business Development & Client Management at CTI, discuss the vital role of patient advocacy groups and the partnership between CTI and the DCM Foundation. Greg shares his journey in founding…
…
continue reading
1
Celebrating 25 Years with CTI's Leadership
29:11
29:11
Play later
Play later
Lists
Like
Liked
29:11In this special 25th-anniversary episode of "Moving Medicine Forward" - The Podcast, we're excited to welcome Tim Schroeder, Chief Executive Officer of CTI, Lynn Fallon, CTI Board Member and former President, and Kevin Schwarz, Chief Operating Officer of CTI. They share insights into CTI’s founding vision and its evolution over the past quarter-cen…
…
continue reading
1
Spotlight: Dr. Monica Shah, Chief Medical Officer at CTI
14:39
14:39
Play later
Play later
Lists
Like
Liked
14:39In this episode of "Moving Medicine Forward" – The Podcast, Dr. Monica Shah, Chief Medical Officer at CTI, discusses her journey into clinical research and her transition into her new role. Dr. Shah shares her immediate priorities and goals as CMO, her leadership style, and her approach to fostering collaboration within CTI. She also expresses her …
…
continue reading
1
Collaborating to Streamline Drug Development
36:45
36:45
Play later
Play later
Lists
Like
Liked
36:45In this episode we delve into the world of regulatory interactions, strategy, & operations with two industry leaders: Dr. Monica Rodriguez, Executive Director of Model-Informed Development, & Christine Norman-Tiner, Executive Director of Global Regulatory & Scientific Affairs. They share their invaluable expertise on: Developing effective regulator…
…
continue reading
1
The Importance of Diversity in Clinical Research
31:02
31:02
Play later
Play later
Lists
Like
Liked
31:02In episode 6 of Moving Medicine Forward, we dive into diversity in clinical research with insights from CTI’s CEO Tim Schroeder and Board Member Dr. Bill Fitzsimmons. Hear about Bill's journey into clinical research, the importance of diversity in clinical trials, and strategies to overcome medical mistrust. We also discuss the latest FDA guidance …
…
continue reading
Episode 5 assembles experts in transplantation. Tim Schroeder and Dr. Bill Fitzsimmons join us to discuss how CTI has been a key player in the field of transplantation, current trends, and where the future of transplantation is heading. Dr. Robert Gatson discusses transplantation innovations and his own background in the field.…
…
continue reading
1
CTI Experts Discuss Cell and Gene Therapy
42:52
42:52
Play later
Play later
Lists
Like
Liked
42:52Episode 4 assembles various CTI experts to discuss Cell and Gene Therapy. In episode 4, Bret Marshall, joins us to discuss CTI’s involvement in Cardiac Cell and Gene trials, our impact, and goals, as well as the current industry trends and advocacy groups. Jaclyn Guillory discussed the groundbreaking advancements in targeted therapies for KRAS muta…
…
continue reading
1
Clinical Research Site Spotlight - Vaccine Trials
31:51
31:51
Play later
Play later
Lists
Like
Liked
31:51Today on Moving medicine forward we have a great discussion with Adam Roth, Vice President, Research Site Services at CTI. In this conversation we take a deep dive into how our Clinical Research Center in Cincinnati OH supports clinical research. We focus on the work the site hasdone on Vaccine trials including how the site supported the Covid-19 V…
…
continue reading
On this episode of “Moving Medicine Forward” - The Podcast, we delve into groundbreaking research with Dr. Richard Curry, Medical Director at CTI. Dr. Curry offers an in-depth look at the ongoing Bexion BXQ350 study, shedding light on the significant advancements and the journey of the trials over recent months. This innovative therapy holds promis…
…
continue reading
1
A Patient's Journey Managing Type 1 Diabetes
29:35
29:35
Play later
Play later
Lists
Like
Liked
29:35Today for our very first episode We will be talking with Christine Eby director of clinical project management and the Therapeutic lead for Rare Disease here at CTI. She will be sharing her son’s patient Journey as her family navigates his Type 1 diabetes Diagnosis.
…
continue reading
CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and…
…
continue reading